CLINICAL_TRIALS
trial_result
· 2020-01-14
Clinical Trial Update: Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis [Phase 1, Phase 2]
Summary
A study updating on TRC101 in chronic kidney disease patients with metabolic acidosis in Phase 1/2; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tricida, Inc. | Conditions: Acidosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-14